Other equities analysts also recently issued research reports about the stock. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Option Care Health from $32.00 to $39.00 in a research note on Friday, April 29th. Zacks Investment Research downgraded shares of Option Care Health from a “buy” rating to a “hold” rating in a research note on Tuesday, May 3rd. Finally, Barrington Research increased their price objective on shares of Option Care Health from $31.00 to $33.00 in a research note on Friday, April 29th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat.com, Option Care Health has a consensus rating of “Buy” and a consensus target price of $31.17.
NASDAQ OPCH opened at $30.02 on Monday. The company has a current ratio of 1.59, a quick ratio of 1.16 and a debt-to-equity ratio of 0.87. The firm has a market capitalization of $5.41 billion, a price-to-earnings ratio of 31.27, a P/E/G ratio of 1.43 and a beta of 1.27. The firm’s 50 day simple moving average is $28.83 and its 200 day simple moving average is $26.67. Option Care Health has a 1 year low of $19.69 and a 1 year high of $31.08.
In related news, COO Harriet Booker sold 6,000 shares of Option Care Health stock in a transaction on Friday, May 6th. The shares were sold at an average price of $28.81, for a total transaction of $172,860.00. Following the completion of the transaction, the chief operating officer now owns 81,511 shares of the company’s stock, valued at $2,348,331.91. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director R Carter Pate sold 1,923 shares of Option Care Health stock in a transaction on Wednesday, June 1st. The stock was sold at an average price of $30.54, for a total transaction of $58,728.42. Following the transaction, the director now directly owns 107,070 shares of the company’s stock, valued at approximately $3,269,917.80. The disclosure for this sale can be found here. Insiders have sold 13,923 shares of company stock valued at $394,668 in the last ninety days. Insiders own 0.22% of the company’s stock.
A number of large investors have recently bought and sold shares of OPCH. Allspring Global Investments Holdings LLC acquired a new stake in Option Care Health in the fourth quarter worth $96,743,000. Marshall Wace LLP acquired a new position in shares of Option Care Health during the fourth quarter valued at about $85,991,000. Venor Capital Management LP acquired a new position in shares of Option Care Health during the fourth quarter valued at about $15,601,000. Norges Bank acquired a new position in shares of Option Care Health during the fourth quarter valued at about $42,794,000. Finally, JPMorgan Chase & Co. grew its holdings in shares of Option Care Health by 172.2% during the fourth quarter. JPMorgan Chase & Co. now owns 2,032,921 shares of the company’s stock valued at $57,816,000 after buying an additional 1,285,972 shares during the last quarter. Institutional investors and hedge funds own 98.23% of the company’s stock.
Option Care Health Company Profile (Get Rating)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
- Get a free copy of the StockNews.com research report on Option Care Health (OPCH)
- Heavy Buying Points to Upside for These 3 Stocks
- 3 Intriguing Stocks With Sub-10 P/E Ratios
- Snap Inc: Revised Guidance & Steeping Losses
- Time to Buy Take-Two Interactive Stock
- 3 Software Plays Showing Signs of Recovery
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.